A phase I study of Aurora kinase A inhibitor LY3295668 erbumine as a single agent and in combination in patients with relapsed/refractory neuroblastoma Meeting Abstract
| Authors: | DuBois, S. G.; Kremer, J. D.; De Wilde, B.; Jacobsen, C.; Aerts, I.; Mosse, Y. P.; Maris, J. M.; Lithio, A.; Gosberg, A.; Banks, C. L.; Tate, C.; Dowless, M.; Gong, X.; Stancato, L.; Bell-McGuinn, K. M.; Park, J. R.; Pearson, A. D. J.; Marachelian, A. |
| Abstract Title: | A phase I study of Aurora kinase A inhibitor LY3295668 erbumine as a single agent and in combination in patients with relapsed/refractory neuroblastoma |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309017 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS10561 |
| Notes: | Meeting Abstract: TPS10561 -- Source: Wos |
